en

PRODUCT DETAIL

MABINOVAN 150 mg

Code 3256E
MA number 65/0075/23-S
Product Form: tbl plg 50x1x150 mg (blis.Al/PVC/PE/PVDC-perfor.-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 65 - ANALGETICA - ANODYNA
ATC:
N NERVOUS SYSTEM
N02 ANALGESICS
N02A OPIOIDS
N02AX Other opioids
N02AX06 Tapentadol
Shelf life: 24
Container: blister Al/PVC/PE/PVDC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to special medical prescription with skew blue stripe.
Legal basis: Article 10(1) generic application
MA issued: 05.04.2023
Validity: 05.04.2028
SPC: SPC_MABINOVAN_03_2023.pdf  
PIL: PIL_MABINOVAN_06.2023.pdf  
Safety feature Yes
Data update: 06.04.2023
eu-flag.png sk-flag.png